New research identifies a potential treatment target for hepatoblastoma, the most common liver cancer in children

byElsevierLeft: Gross images of livers from mice transfected with β-catenin and YAP1(β-Y), β-catenin and YAP1 plus dominant negative HSF1 (dnHSF1-β-Y) and normal (control). Right: Liver to body

Updated on: January 13,2024

New research identifies a potential treatment target for hepatoblastoma, the most common liver cancer in children

byElsevierLeft: Gross images of livers from mice transfected with β-catenin and YAP1(β-Y), β-catenin and YAP1 plus dominant negative HSF1 (dnHSF1-β-Y) and normal (control). Right: Liver to body

Updated on:January 13,2024

Swallowable device to detect Barrett's esophagus receives FDA 510(k) clearance

by Case Western Reserve University"FDA clearance of the EsoCheck device means the device is now available to patients and physicians as a non-endoscopic method for sampling the esophagus. Th

Updated on: May 09,2024

Swallowable device to detect Barrett's esophagus receives FDA 510(k) clearance

by Case Western Reserve University"FDA clearance of the EsoCheck device means the device is now available to patients and physicians as a non-endoscopic method for sampling the esophagus. Th

Updated on:May 09,2024

Adding metastasis-directed radiation therapy boosts progression-free survival in metastatic pancreatic cancer

byUniversity of Texas M. D. Anderson Cancer CenterCredit: Unsplash/CC0 Public DomainResearchers from The University of Texas MD Anderson Cancer Center have demonstrated that adding metastasis-di

Updated on: August 28,2024

Adding metastasis-directed radiation therapy boosts progression-free survival in metastatic pancreatic cancer

byUniversity of Texas M. D. Anderson Cancer CenterCredit: Unsplash/CC0 Public DomainResearchers from The University of Texas MD Anderson Cancer Center have demonstrated that adding metastasis-di

Updated on:August 28,2024

Many breast cancer survivors do not receive genetic testing, despite being eligible

by Nicole Fawcett,University of MichiganCredit: Unsplash/CC0 Public DomainAs cancer treatment and survivorship care relies more on understanding the genetic make-up of an individual's tumor,

Updated on: July 17,2024

Many breast cancer survivors do not receive genetic testing, despite being eligible

by Nicole Fawcett,University of MichiganCredit: Unsplash/CC0 Public DomainAs cancer treatment and survivorship care relies more on understanding the genetic make-up of an individual's tumor,

Updated on:July 17,2024

Scientists find way to starve breast cancer cells

by Jennifer Michalowski,Cold Spring Harbor LaboratoryWhen fast-growing breast cancer cells run out of glutamine, they turn to an alternative supply line. PHGDH (above, in green) is a key enzyme

Updated on: September 07,2024

Scientists find way to starve breast cancer cells

by Jennifer Michalowski,Cold Spring Harbor LaboratoryWhen fast-growing breast cancer cells run out of glutamine, they turn to an alternative supply line. PHGDH (above, in green) is a key enzyme

Updated on:September 07,2024

Aggressive breast cancers store large amounts of energy, which enables it to spread: study

by University of MichiganSofia Merajver, M.D., Ph.D. Credit: University of Michigan Rogel Cancer CenterCancer cells—especially the more aggressive ones—seem to have an ability to change. It's

Updated on: June 28,2024

Aggressive breast cancers store large amounts of energy, which enables it to spread: study

by University of MichiganSofia Merajver, M.D., Ph.D. Credit: University of Michigan Rogel Cancer CenterCancer cells—especially the more aggressive ones—seem to have an ability to change. It's

Updated on:June 28,2024

Innovations in cancer treatment through targeted bacterial vaccines

byScience China PressThe schematic illustrates how the nanovaccine induces robust anti-F. nucleatum immune responses that significantly improve the efficiency of chemotherapy and reduce cancer m

Updated on: September 10,2024

Innovations in cancer treatment through targeted bacterial vaccines

byScience China PressThe schematic illustrates how the nanovaccine induces robust anti-F. nucleatum immune responses that significantly improve the efficiency of chemotherapy and reduce cancer m

Updated on:September 10,2024

Tumor cells' response to chemotherapy is driven by randomness, shows study

byGarvan Institute of Medical ResearchNeuroblastoma cells (cyan) growing as a tumour and the surrounding collagen matrix (magenta). The cells are expressing a biosensor (JNK-KTR) that reads out

Updated on: January 23,2024

Tumor cells' response to chemotherapy is driven by randomness, shows study

byGarvan Institute of Medical ResearchNeuroblastoma cells (cyan) growing as a tumour and the surrounding collagen matrix (magenta). The cells are expressing a biosensor (JNK-KTR) that reads out

Updated on:January 23,2024

New chemical weapon to combat cancer

by University of GenevaMultipolar melanoma cells stained for centrosomes (gamma-tubulin in red, centrin in green) and DNA (DAPI in blue). Scale bar represents 5 µm. Credit: UNIGEUNIGE researchers

Updated on: March 01,2024

New chemical weapon to combat cancer

by University of GenevaMultipolar melanoma cells stained for centrosomes (gamma-tubulin in red, centrin in green) and DNA (DAPI in blue). Scale bar represents 5 µm. Credit: UNIGEUNIGE researchers

Updated on:March 01,2024

Perspective on management of LDCT findings on low-dose computed tomography examinations for lung cancer screening

by International Association for the Study of Lung CancerTop 10 global causes of deaths,2016. Credit:Journal of Thoracic Oncology(2023). DOI: 10.1016/j.jtho.2023.11.013Annual low-dos

Updated on: December 28,2023

Perspective on management of LDCT findings on low-dose computed tomography examinations for lung cancer screening

by International Association for the Study of Lung CancerTop 10 global causes of deaths,2016. Credit:Journal of Thoracic Oncology(2023). DOI: 10.1016/j.jtho.2023.11.013Annual low-dos

Updated on:December 28,2023

High-resolution brain tumor mapping reveals possible reason why some patients don't respond to new drug

byWeizmann Institute of ScienceGraphical abstract. Credit:Cell(2024). DOI: 10.1016/j.cell.2024.03.029The cells that make up cancerous brain tumors are extremely varied and sometimes

Updated on: September 10,2024

High-resolution brain tumor mapping reveals possible reason why some patients don't respond to new drug

byWeizmann Institute of ScienceGraphical abstract. Credit:Cell(2024). DOI: 10.1016/j.cell.2024.03.029The cells that make up cancerous brain tumors are extremely varied and sometimes

Updated on:September 10,2024

Enlarged genotype-phenotype correlation for a three-base pair deletion in neurofibromatosis type 1

by Jeff Hansen,University of Alabama at BirminghamLudwine Messiaen, Ph.D., left, and Magdalena Koczkowska, Ph.D. Credit: University of Alabama at BirminghamInternational collaborative research l

Updated on: March 14,2024

Enlarged genotype-phenotype correlation for a three-base pair deletion in neurofibromatosis type 1

by Jeff Hansen,University of Alabama at BirminghamLudwine Messiaen, Ph.D., left, and Magdalena Koczkowska, Ph.D. Credit: University of Alabama at BirminghamInternational collaborative research l

Updated on:March 14,2024